| SC 13G/A | 2024-02-14 | Madison Avenue Partners, LP | Ovid Therapeutics Inc. | 3,648,509 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-14 | LEVIN JEREMY M | Ovid Therapeutics Inc. | 6,942,181 | 9.4% | EDGAR |
| SC 13G/A | 2024-02-12 | Rubric Capital Management LP | Ovid Therapeutics Inc. | 5,315,969 | 7.5% | EDGAR |
| SC 13G | 2024-01-29 | BlackRock Inc. | Ovid Therapeutics Inc. | 4,319,918 | 6.1% | EDGAR |
| SC 13G | 2023-07-31 | Madison Avenue Partners, LP | Ovid Therapeutics Inc. | 3,609,054 | 5.1% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Ovid Therapeutics Inc. | 3,631,500 | 5.2% | EDGAR |
| SC 13G/A | 2023-02-14 | LEVIN JEREMY M | Ovid Therapeutics Inc. | 7,281,121 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-13 | Stonepine Capital Management, LLC | Ovid Therapeutics Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-10 | EcoR1 Capital, LLC | Ovid Therapeutics Inc. | 6,117,400 | 8.7% | EDGAR |
| SC 13G | 2023-02-10 | Rubric Capital Management LP | Ovid Therapeutics Inc. | 6,828,065 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Ovid Therapeutics Inc. | 2,581,736 | 3.7% | EDGAR |
| SC 13G/A | 2023-02-03 | TAKEDA PHARMACEUTICAL CO LTD | Ovid Therapeutics Inc. | 8,781,996 | 12.2% | EDGAR |
| SC 13G/A | 2022-02-14 | Stonepine Capital Management, LLC | Ovid Therapeutics Inc. | 4,006,185 | 5.9% | EDGAR |
| SC 13G/A | 2022-02-14 | EcoR1 Capital, LLC | Ovid Therapeutics Inc. | 6,082,200 | 8.9% | EDGAR |
| SC 13G/A | 2022-02-14 | LEVIN JEREMY M | Ovid Therapeutics Inc. | 6,554,770 | 9.4% | EDGAR |
| SC 13G/A | 2022-02-14 | During Matthew | Ovid Therapeutics Inc. | 3,103,932 | 4.5% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | Ovid Therapeutics Inc. | 3,442,618 | 5.1% | EDGAR |
| SC 13G | 2021-07-12 | BlackRock Inc. | Ovid Therapeutics Inc. | 1,202,730 | 1.8% | EDGAR |
| SC 13G | 2021-04-29 | Stonepine Capital Management, LLC | Ovid Therapeutics Inc. | 3,500,000 | 5.3% | EDGAR |
| SC 13G/A | 2021-04-15 | BIOTECHNOLOGY VALUE FUND L P | Ovid Therapeutics Inc. | 3,411,500 | 5.2% | EDGAR |